[1]
« Practical Considerations for Early Relapsed/Refractory Multiple Myeloma in the Canadian Landscape in 2025 », Can Hematol Today, vol. 4, nᵒ s01, p. 2–11, janv. 2025, doi: 10.58931/cht.2025.4s0161.